GB0507561D0 - Modulation of an immune response by filamentous haemagglutinin - Google Patents

Modulation of an immune response by filamentous haemagglutinin

Info

Publication number
GB0507561D0
GB0507561D0 GBGB0507561.9A GB0507561A GB0507561D0 GB 0507561 D0 GB0507561 D0 GB 0507561D0 GB 0507561 A GB0507561 A GB 0507561A GB 0507561 D0 GB0507561 D0 GB 0507561D0
Authority
GB
United Kingdom
Prior art keywords
modulation
immune response
filamentous haemagglutinin
haemagglutinin
filamentous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0507561.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TRINITY OF QUEEN ELIZABETH NEA
College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin
Original Assignee
TRINITY OF QUEEN ELIZABETH NEA
College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TRINITY OF QUEEN ELIZABETH NEA, College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin filed Critical TRINITY OF QUEEN ELIZABETH NEA
Priority to GBGB0507561.9A priority Critical patent/GB0507561D0/en
Publication of GB0507561D0 publication Critical patent/GB0507561D0/en
Priority to PCT/IB2006/001563 priority patent/WO2006109195A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0007—Nervous system antigens; Prions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GBGB0507561.9A 2005-04-14 2005-04-14 Modulation of an immune response by filamentous haemagglutinin Ceased GB0507561D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0507561.9A GB0507561D0 (en) 2005-04-14 2005-04-14 Modulation of an immune response by filamentous haemagglutinin
PCT/IB2006/001563 WO2006109195A2 (en) 2005-04-14 2006-04-18 Modulation of an immune response by filamentous haemagglutinin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0507561.9A GB0507561D0 (en) 2005-04-14 2005-04-14 Modulation of an immune response by filamentous haemagglutinin

Publications (1)

Publication Number Publication Date
GB0507561D0 true GB0507561D0 (en) 2005-05-18

Family

ID=34611130

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0507561.9A Ceased GB0507561D0 (en) 2005-04-14 2005-04-14 Modulation of an immune response by filamentous haemagglutinin

Country Status (2)

Country Link
GB (1) GB0507561D0 (en)
WO (1) WO2006109195A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI426918B (en) 2007-02-12 2014-02-21 Merck Sharp & Dohme Use of il-23 antagonists for treatment of infection
EP2892353A4 (en) * 2012-09-10 2016-10-26 Yeda Res & Dev Individualized immunomodulation therapy for neurodegenerative disorders, cns injury and age-related dementia

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005034983A1 (en) * 2003-10-14 2005-04-21 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth, Near Dublin Filamentous haemagglutinin in the treatment and/or prophylaxis of immune-mediated disorders

Also Published As

Publication number Publication date
WO2006109195A2 (en) 2006-10-19
WO2006109195A3 (en) 2007-04-05

Similar Documents

Publication Publication Date Title
GB0516703D0 (en) Novel insecticides
GB0500605D0 (en) Photodetector assembly
GB0521796D0 (en) Gtgvr software application
EP2380976A4 (en) Human anti-human influenza virus antibody
GB2440498B (en) Adhesive enhancing support bra
GB2423693B (en) Improved cookware
PL1969232T3 (en) Diaphragm circulator
EP1961415A4 (en) Adhesive preparation
HK1214534A1 (en) Influenza vaccination
EP2276833A4 (en) Modulation of the immune response
GB0805312D0 (en) Modulation of the immune response
ITMO20050238A1 (en) COOKING SYSTEM
GB0520192D0 (en) Improved adhesive bra
EP2086526A4 (en) Induction of an immune response against dengue virus using prime-boost approach
GB0507561D0 (en) Modulation of an immune response by filamentous haemagglutinin
GB0515716D0 (en) Trampoline assembly
DE602005007850D1 (en) cooker
GB0507989D0 (en) Novel insecticides
GB2476767B (en) Method of modifying the immune response
ES1061156Y (en) MULTIPLAN KITCHEN
DE602005019226D1 (en) cooker
SI1772179T1 (en) Securing flange
ITMO20050274A1 (en) COOKING SYSTEM
GB0523243D0 (en) Control of immune responses
GB0523242D0 (en) Control of immune responses

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)